Abiopharma

(99% Neutral) CISCO SYSTEMS, INC. (CSCO) Announces New Board Appointment

WELLS SCOTT 🟡 adjusted position in 1.5M shares of Clear Channel Outdoor Holdings, Inc. (CCO) at $2.40 ($1.5M) Transaction Date: Apr 29, 2026 | Filing ID: 201398

LEIFRAS CO., LTD. (LFS) Files Form 6-K

McCuin Robert 🟡 adjusted position in 311.0K shares of Clear Channel Outdoor Holdings, Inc. (CCO) at $2.40 Transaction Date: Apr 29, 2026 | Filing ID: 201396

Myomo to Report First Quarter 2026 Financial Results on May 7

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Methode Electronics to Present at the Virtual Oppenheimer Industrial Growth Conference

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Angel Oak Financial Strategies Income Term Trust Declares May 2026 Distribution

GigCapital7 Corp. Announces Non-Redemption Agreements Funding in the Approximate Amount of at Least $19.3 Million in Conjunction with the Anticipated Closing of the Business Combination with Hadron Energy, Inc.

InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System

Summary Notice of Proposed Settlement of Derivative Action

Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Durable Hormone Control, Reduced Glucocorticoid Exposure and Meaningful Clinical Improvements in Pediatric Patients with Classic Congenital Adrenal Hyperplasia

Heidmar Announces Filing of Its 2025 Annual Report on Form 20-F